Secret cannabis users may not have to keep their habits secret much longer. American companies across different industries are finally getting rid of pre-employment tests. By dropping such tests for potential employees companies save money while ensuring they are not losing out on talent.
Let’s take a look at how businesses are parting ways with traditional “cannabis tests” as well as how legal access leads to fair employment opportunities for consumers alike.
The origins of pre-employment drug testing trace back to the 1980s. At this time, the United States was immersed in the War on Drugs. Notably, President Ronald Reagan’s administration implemented the Drug-Free Workplace Act of 1988, which mandated drug-free workplace environments.
This legislation was intended to create safe and productive workplaces free from the influence of illegal substances. At that time, illicit substances were perceived as a significant threat to both workplace productivity and safety.
Fast forward to the present and the way society perceives cannabis has drastically shifted. This shift is driven by the increasing recognition of the medical advantages of cannabis, as well as evolving social values and norms.
Public opinion polls show the scale of these shifting tides with many Americans now recognizing cannabis’s therapeutic potential. According to 2021 research from the National Institutes of Health (NIH), 18.7% of individuals aged 12 or older, approximately 52.5 million people, used cannabis in the past year.
Beyond emerging scientific research, popular culture has also played an instrumental role in cannabis’ normalization. Hollywood films, influential celebrities, and even some mainstream media have portrayed cannabis in a more positive or neutral light, removing associated negative connotations.
Public opinion has resulted in significant changes in cannabis laws in the United States. Unfortunately, not all states took the same approach. As such, there is much variance between each state’s set of regulations, like possession limits and cultivation rights. Despite this, the real challenge is closing the gap between state-level and federal cannabis laws.
In spite of all the progress at the state level, cannabis remains classified as a Schedule I substance at the federal level. This has posed challenges for businesses operating across state lines or with federal contracts. Additionally, it has sparked debates regarding jurisdiction, especially when cannabis possession or consumption crosses federal lines or properties.
Veriheal has satisfied millions of patients nationwide by giving them access to these benefits
As more states join the legalization movement, there is growing hope and speculation that national regulations will catch up with progressive state policies.
As many states shift towards acceptance, many companies find it less beneficial—and sometimes counterproductive—to maintain strict cannabis testing policies. For one, the costs associated with drug screening can be significant. When balancing these against the diminishing perceived risks of cannabis, the scales often tip in favor of omitting the test.
Furthermore, in a competitive job market, businesses are recognizing that less restrictive policies on cannabis can be a decisive factor for potentially exceptional and talented hires. By not testing for cannabis, companies can widen their talent pool. This attracts individuals who use cannabis, either recreationally or medicinally, in areas where it’s legal.
However, it’s worth noting that certain industries need to prioritize safety, such as the Department of Transportation (DOT) and healthcare. These sectors remain cautious and continue to enforce stringent drug-testing protocols.
As society continues to evolve, the perception and regulation of cannabis are becoming significant indicators of our changing times. Once stigmatized and condemned, cannabis now finds itself in a more accepted position.
Thankfully, employers, recognizing the changing landscape, are reevaluating their approach to pre-employment drug testing. By doing so, they not only reflect society’s increasing acceptance of cannabis but also help establish workplace standards for the future. It may literally be the difference between a company’s survival and failure.
With the “green wave” gaining momentum, our perceptions and policies concerning cannabis are on the verge of historic change.
Note: The content on this page is for informational purposes only and is not intended to be professional medical advice. Do not attempt to self-diagnose or prescribe treatment based on the information provided. Always consult a physician before making any decision on the treatment of a medical condition.
With the arrival of 4/20 comes the promise of festivals, mass smoke sessions, and camaraderie with fellow cannabis enthusiasts. But, while cannabis may promote social gathering for some, others prefer to consume their cannabis in the way of the introvert – that is, completely alone. If you’re not exactly a social smoker and still want…
It’s become increasingly common to hear stories of those suffering from serotonin syndrome, but for some, the full scope and depth of this mysterious condition remain shrouded in mystery. Are psychedelic drugs and cannabis capable of triggering this serious medical issue? In this post, we’ll dive into what serotonin syndrome is, how you may be…
The legendary stoner holiday 4/20 is upon us, and so are the transits and astrological happenings associated with it. As spring and warm weather begin to roll in, spirits lift, and people spend more time outside under the sun—and, of course, the stars. Smoking under the night sky is a thrilling experience. Whether you’re a…
Hash is more than just a hot trend with ancient origins: it’s the future of medical cannabis consumption. Because this form of concentrate is deliberately engineered to preserve the natural terpenes and cannabinoid profile of the cannabis plant, dabbing hash is perhaps the most efficient way to seek the potential benefits of medical marijuana –…
Cannabis use is increasing all around the world. The American marijuana industry was worth about $57 billion in 2023 and is projected to reach $444 billion by 2030, a staggering growth that reflects it as the fastest-growing industry anywhere in the world. Veriheal consistently stays abreast of current trends by conducting routine surveys among our…
Get your medical marijuana card today
Sign up in under 5 minutes
